Advertisement
Home 2019 April

Monthly Archives: April 2019

For older patients undergoing allogeneic hematopoietic cell transplantation

Population Mortality Affects Long-Term Follow-Up of AlloHCT

0
Substantial part of total nonrelapse mortality for older patients due to population mortality
About one in eight Americans borrowed a total of $88 billion in the past year to pay for health care

Americans Borrowed $88 Billion in Past Year to Pay for Health Care

0
Many do not seek treatment for health issues due to cost or reduce spending to pay for health care
The number of measles cases in the United States so far this year has already surpassed the total for last year.

U.S. Measles Cases Already Top Last Year’s Total

0
387 reported cases in 15 states as of March 28
For Medicare beneficiaries with mild cognitive impairment or dementia of uncertain etiology

Amyloid PET Linked to Changes in Management for MCI, Dementia

0
Change in management between pre-, post-PET visits for 60.2 and 63.5 percent with MCI, dementia
For patients with human epidermal growth factor receptor 2-positive stage IV breast cancer

AACR: Surgery Tied to Improved Survival in HER2+ Breast Cancer

0
In addition to targeted medication, adjuvant therapy, surgery improves survival in stage IV disease
Prostate cancer incidence and mortality rates are decreasing or stabilizing in most countries

AACR: Prostate Cancer Incidence Dropping, Stable in Most Countries

0
Decreases in mortality seen in 14 countries, stabilization in 54 of 71 countries
Sex hormones may impact the risk for asthma

Sex Hormone Levels May Impact Development of Asthma

0
Genetic evidence shows elevated SHBG levels may protect against asthma, mostly in females
For adults with lower-extremity joint symptoms

One Hour of Activity/Week Helps Maintain Disability-Free Status

0
Findings seen among adults aged ≥49 years at elevated disability risk due to lower-extremity joint symptoms
Dolutegravir should be considered for antiretroviral therapy in treating HIV in women of childbearing potential in resource-limited settings

Dolutegravir Feasible for HIV Tx in Women of Childbearing Age

0
Risk for neural tube defects offset by fewer deaths among women, decreased sexual HIV transmission
For patients with advanced small cell lung cancer

AACR: Pembrolizumab Beneficial for Advanced Small Cell Lung Cancer

0
Antitumor activity promising; objective response rate 19.3 percent for patients with incurable, advanced SCLC